{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:58:55Z","timestamp":1790233135093,"version":"4.1.0"},"reference-count":139,"publisher":"American Chemical Society (ACS)","issue":"5","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-001"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-009"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACS Pharmacol. Transl. Sci."],"published-print":{"date-parts":[[2020,10,9]]},"DOI":"10.1021\/acsptsci.0c00109","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T09:48:48Z","timestamp":1600422528000},"page":"844-858","source":"Crossref","is-referenced-by-count":39,"title":["SARS-CoV-2 Vaccine Development: An Overview and Perspectives"],"prefix":"10.1021","volume":"3","author":[{"given":"Yi","family":"Liu","sequence":"first","affiliation":[{"name":"Molecular Imaging Program at Stanford (MIPS), Stanford University, 3155 Porter Drive, Palo Alto, California 94304, United States"},{"name":"Department of Critical Care Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Molecular Imaging Program at Stanford (MIPS), Stanford University, 3155 Porter Drive, Palo Alto, California 94304, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9694-1408","authenticated-orcid":true,"given":"Tarik F.","family":"Massoud","sequence":"additional","affiliation":[{"name":"Molecular Imaging Program at Stanford (MIPS), Stanford University, 3155 Porter Drive, Palo Alto, California 94304, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7155-4738","authenticated-orcid":true,"given":"Ramasamy","family":"Paulmurugan","sequence":"additional","affiliation":[{"name":"Molecular Imaging Program at Stanford (MIPS), Stanford University, 3155 Porter Drive, Palo Alto, California 94304, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0695-z"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2334-5"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2169-0"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-00945-4"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr4200"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1007\/s13304-020-00804-8"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13382"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-00934-7"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2020.00455"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001316"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1038\/nature07231"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02877-8"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17165844"},{"key":"ref18\/cit18","doi-asserted-by":"crossref","unstructured":"Somani, S., Richter, F., Fuster, V., De Freitas, J., Naik, N., Sigel, K., Boettinger, E. P., Levin, M. A., Fayad, Z., and Just, A. C.  (May 22, 2020) Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization For COVID-19.  medRxiv (Health Systems and Quality Improvement), 2020.05.17.20104604, https:\/\/doi.org\/10.1101\/2020.05.17.20104604 (accessed August 25, 2020).","DOI":"10.1101\/2020.05.17.20104604"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00567-20"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2020.1739001"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4776"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc5343"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414221"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftaa025"},{"key":"ref25\/cit25","unstructured":"Mayo Clinic. (June 06, 2020) Herd immunity and COVID-19\n(coronavirus): What you need to know, https:\/\/www.mayoclinic.org\/diseases-conditions\/coronavirus\/in-depth\/herd-immunity-and-coronavirus\/art-20486808 (accessed August 25, 2020)."},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2004999117"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25902"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.8.5490"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.10.008"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00122"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1038\/nature12711"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2017.1271415"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.015"},{"key":"ref37\/cit37","doi-asserted-by":"crossref","unstructured":"Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Asthagiri Arunkumar, G., Jurczyszak, D., and Polanco, J.  (April 16, 2020) A serological assay to detect SARS-CoV-2 seroconversion in humans.  medRxiv (Allergy and Immunology), 2020.03.17.20037713, https:\/\/doi.org\/10.1101\/2020.03.17.20037713 (accessed August 25, 2020).","DOI":"10.1101\/2020.03.17.20037713"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.16.2000421"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc8413"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.3201\/eid2307.170310"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000636"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800048019"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030237"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.3390\/v11010060"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1038\/nature02463"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2972"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903490"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.03.036"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-009-0409-6"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.11.006"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.8.5490"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1089\/088282403763635465"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035421"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.05.015"},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-92165-3_20"},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.013"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv067"},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31187-9"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01542-10"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02205-08"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01626-9"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007621"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15813"},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-4091"},{"key":"ref66\/cit66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223784"},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.02.056"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1502864112"},{"key":"ref69\/cit69","unstructured":"Codagenix. (2020) Our vaccine pipeline: excellent clinical safety profile and robust\nimmunogenicity, https:\/\/codagenix.com\/vaccine-programs\/pipeline\/ (accessed August 25, 2020)."},{"key":"ref70\/cit70","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.11.054"},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc1932"},{"key":"ref72\/cit72","unstructured":"Zhihao, Z. (April 15, 2020) Three COVID-19 vaccines approved for clinical trials.  China Daily, https:\/\/covid-19.chinadaily.com.cn\/a\/202004\/15\/WS5e965bb8a3105d50a3d163de.html (accessed August 25, 2020)."},{"key":"#cr-split#-ref73\/cit73.1","unstructured":"National Medical Products Administration. (June 22, 2020) COVID-19 vaccine"},{"key":"#cr-split#-ref73\/cit73.2","unstructured":"reaches phase-2 trials in China, http:\/\/english.nmpa.gov.cn\/2020-06\/22\/c_502093.htm (accessed August 25, 2020)."},{"key":"ref74\/cit74","unstructured":"Clinical Trials. (June 30, 2020) India\u2019s first\nCovid-19 vaccine by Bharat Biotech to enter trials, https:\/\/www.clinicaltrialsarena.com\/news\/india-bharat-biotech-vaccine-trials\/ (accessed August 25, 2020)."},{"key":"ref75\/cit75","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1993.9.1175"},{"key":"ref76\/cit76","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3180686ce0"},{"issue":"4","key":"ref77\/cit77","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.151.4.2032","volume":"151","author":"Graham B. S.","year":"1993","journal-title":"J. Immunol"},{"key":"ref78\/cit78","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1743767"},{"key":"ref79\/cit79","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.6.4.591"},{"key":"ref80\/cit80","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.01.111"},{"key":"ref81\/cit81","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2224"},{"key":"ref82\/cit82","unstructured":"University of Queensland Communications. (April 29, 2020) UQ\nCOVID-19 vaccine shown to induce potent protective response in pre-clinical\ntrials.  University of Queensland, https:\/\/www.uq.edu.au\/news\/article\/2020\/04\/uq-covid-19-vaccine-shown-induce-potent-protective-response-pre-clinical-trials (accessed August 25, 2020)."},{"key":"ref83\/cit83","unstructured":"Nucleus Network. (April 16, 2020) Novavax\nto commence COVID-19 vaccine\ntrial with Nucleus Network.  BioSpace, https:\/\/www.biospace.com\/article\/releases\/novavax-to-commence-covid-19-vaccine-trial-with-nucleus-network\/ (accessed August 25, 2020)."},{"key":"ref84\/cit84","unstructured":"Dynavax Technologies Corporation. (March 24, 2020) Dynavax\nand Clover Biopharmaceuticals Announce Research Collaboration to Evaluate\nCoronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant.  Dynavax, https:\/\/investors.dynavax.com\/news-releases\/news-release-details\/dynavax-and-clover-biopharmaceuticals-announce-research (accessed August 25, 2020)."},{"key":"ref85\/cit85","unstructured":"Texas Children\u2019s Hospital. (2020) Vaccine Development\n(Center for Vaccine Development). https:\/\/www.texaschildrens.org\/departments\/vaccine-development (accessed August 25, 2020)."},{"key":"ref86\/cit86","unstructured":"Kutak, J.(April 9, 2020) Axon Neuroscience Has a Promising Peptide Vaccine Against COVID-19 in Development.  Biospace, https:\/\/www.biospace.com\/article\/releases\/axon-neuroscience-has-a-promising-peptide-vaccine-against-covid-19-in-development\/ (accessed August 25, 2020)."},{"key":"ref87\/cit87","unstructured":"NuGenerex. (2020) COVID-19 &\nthe 2019-nCOV Ii-Key Vaccine Project. https:\/\/storage.googleapis.com\/wzukusers\/user-26831283\/documents\/5e73891471930g8BqVxh\/Ii-Key-nCOV%20Peptide%20Vaccine.Overview.3%2019%2020.pdf (accessed August 25, 2020)."},{"key":"ref88\/cit88","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2683286"},{"key":"ref89\/cit89","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.065"},{"key":"ref90\/cit90","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31208-3"},{"key":"ref91\/cit91","unstructured":"Wescott, B. (June 30, 2020) Beijing approves experimental Covid-19 vaccine for use in Chinese military.  CNN Health, https:\/\/www.cnn.com\/2020\/06\/30\/health\/china-coronavirus-military-vaccine-intl-hnk-scli\/index.html (accessed August 25, 2020)."},{"key":"ref92\/cit92","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31208-3"},{"key":"ref93\/cit93","unstructured":"Johnson & Johnson. Our COVID-19 Response Efforts. jnj.com\/coronavirus (accessed\nAugust 25, 2020)."},{"key":"ref94\/cit94","unstructured":"University of Oxford. (June 28, 2020) Trial\nof Oxford COVID-19 vaccine starts in Brazil. https:\/\/www.ox.ac.uk\/news\/2020-06-28-trial-oxford-covid-19-vaccine-starts-brazil (accessed August 25, 2020)."},{"key":"ref95\/cit95","unstructured":"Biehn, B. (May 20, 2020)Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate.  BioSpace, https:\/\/www.biospace.com\/article\/releases\/vaxart-announces-selection-of-its-oral-covid-19-vaccine-lead-candidate\/ (accessed August 25, 2020)."},{"key":"ref96\/cit96","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(08)60367-X"},{"key":"ref97\/cit97","unstructured":"Sharma, S. (May 14, 2020) This Italian startup is working hard to develop the first vaccine to kill coronavirus: Will it win the race? Silicon Canals, https:\/\/siliconcanals.com\/news\/italian-startup-vaccine-coronavirus\/ (accessed August 25, 2020)."},{"key":"ref98\/cit98","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2014.901308"},{"key":"ref99\/cit99","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.200"},{"key":"ref100\/cit100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.12.032"},{"key":"ref101\/cit101","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2017.5"},{"key":"ref102\/cit102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022483"},{"key":"ref103\/cit103","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32833cfe32"},{"key":"ref104\/cit104","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.104"},{"key":"ref105\/cit105","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/548280"},{"key":"ref106\/cit106","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.8.3.333"},{"key":"ref107\/cit107","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2090"},{"key":"ref108\/cit108","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.43"},{"key":"ref109\/cit109","doi-asserted-by":"publisher","DOI":"10.1086\/315871"},{"key":"ref110\/cit110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.08.020"},{"key":"ref111\/cit111","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2012.0536"},{"key":"ref112\/cit112","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxl114"},{"key":"ref113\/cit113","doi-asserted-by":"publisher","DOI":"10.1021\/jm0110441"},{"key":"ref114\/cit114","unstructured":"Taylor, N. P. (June 17, 2020) CureVac gets OK to start testing mRNA COVID-19 vaccine in humans.  Fierce Biotech, https:\/\/www.fiercebiotech.com\/biotech\/curevac-gets-ok-to-start-testing-mrna-covid-19-vaccine-humans (accessed August 25, 2020)."},{"key":"ref115\/cit115","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.9b20071"},{"key":"ref116\/cit116","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.200"},{"key":"ref117\/cit117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.08.005"},{"key":"ref118\/cit118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.05.009"},{"key":"ref119\/cit119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.07.024"},{"key":"ref120\/cit120","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243"},{"key":"ref121\/cit121","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0377-3"},{"key":"ref122\/cit122","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31665-3"},{"key":"ref123\/cit123","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.035"},{"key":"ref124\/cit124","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031583"},{"key":"ref125\/cit125","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3159"},{"key":"ref126\/cit126","doi-asserted-by":"publisher","DOI":"10.4155\/fsoa-2017-0151"},{"key":"ref127\/cit127","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.1.309"},{"key":"ref128\/cit128","doi-asserted-by":"publisher","DOI":"10.1038\/srep11315"},{"key":"ref129\/cit129","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.02.018"},{"key":"ref130\/cit130","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015024"},{"key":"ref131\/cit131","doi-asserted-by":"publisher","DOI":"10.1089\/ten.tea.2017.0485"},{"key":"ref132\/cit132","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.49"},{"key":"ref133\/cit133","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2020.4596"},{"key":"ref134\/cit134","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.28"},{"key":"ref135\/cit135","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.38"},{"key":"ref136\/cit136","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.01.013"},{"key":"ref137\/cit137","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0159-8"},{"key":"ref138\/cit138","doi-asserted-by":"publisher","DOI":"10.4155\/tde-2016-0006"}],"container-title":["ACS Pharmacology & Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsptsci.0c00109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:26:49Z","timestamp":1682483209000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acsptsci.0c00109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":139,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10,9]]}},"alternative-id":["10.1021\/acsptsci.0c00109"],"URL":"https:\/\/doi.org\/10.1021\/acsptsci.0c00109","relation":{},"ISSN":["2575-9108","2575-9108"],"issn-type":[{"value":"2575-9108","type":"print"},{"value":"2575-9108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]}}}